Effects of various mucosal protective drugs on diethyldithiocarbamate-induced antral ulcer in rats.
This study was designed to determine the effects of exogenous Cu,Zn-superoxide dismutase (SOD) and various mucosal protective agents against antral ulcer induced by diethyldithiocarbamate (DDC), inhibitor of Cu,Zn-SOD. Exogenous Cu,Zn-SOD reduced ulcer formation and prevented a decrease in SOD activity in gastric mucosa. This result indicates that maintenance of mucosal SOD activity is essential to prevent the ulcerogenicity of DDC. Many mucosal protective drugs that increase blood flow, mucus secretion, and endogenous prostaglandin failed to prevent ulcer formation and decrease of mucosal SOD activity. Rebamipide, however, significantly reduced ulcerogenesis and maintained mucosal SOD activity. This suggests that rebamipide has new protective effects on gastric mucosa.
Oka
S
S
Kokura Memorial Hospital, Kitakyushu, Japan.
Ogino
K
K
Hobara
T
T
Yoshimura
S
S
Okazaki
Y
Y
Takemoto
T
T
Iida
Y
Y
D000409:Alanine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D004050:Ditiocarb / Q000494:pharmacology*; D008297:Male; D011706:Pyloric Antrum; D015363:Quinolones / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013276:Stomach Ulcer / Q000139:chemically induced / Q000517:prevention & control*; D013482:Superoxide Dismutase / Q000494:pharmacology
D000897:Anti-Ulcer Agents; D015363:Quinolones; D004050:Ditiocarb; D013482:Superoxide Dismutase; C052785:rebamipide; D000409:Alanine